Updates
-
tMMJ-002, a cannabis investigational product for the treatment of Huntington’s disease, has been granted Orphan Drug designation by the U.S. Food and Drug Administration, announced its developer MMJ ... Read more
-
Vienna to Host RARE2019 Meeting on Rare Diseases
About 100 scientists, researchers, pharmaceutical executives, and others will converge on Austria’s capital city early next month for the 2nd International Congress on Advanced ... Read more -
Emotional Recognition Defect Linked to Apathy in Huntington’s, Study Shows
Impairment in emotional recognition — the process of identifying human emotion, most typically from facial expressions, particularly happy ones — seems to be linked ... Read more -
Researchers Get $6 Million to Continue Work on Huntington’s Stem Cell Therapy
In support of ongoing development of a prospective new therapy for Huntington’s disease, the California Institute for Regenerative Medicine (CIRM) has awarded University of ... Read more -
Fast Screening Strategy Identifies Potential New Inhibitors for Huntington’s Disease
Several small molecules have been identified by the Alborada Drug Discovery Institute as potential inhibitors to help halt the underlying mechanisms that drive the development of neurodegenerative ... Read more
-
Patients, Family and Friends to Take Part in Variety of Rare Disease Day Events Worldwide
Scores of events are afoot worldwide to mark Feb. 28, Rare Disease Day 2019. The activities ... -
Impaired Glial Cell Development Contributes To Huntington’s, Mouse Study Suggests
Dysfunction in the development and maturation of the brain’s primary support cells, know as ... -
Phase 3 Trial of RG6042 Will Gauge Potential of Gene-silencing Approaches for Huntington’s, Other Diseases
The upcoming Phase 3 trial of RG6042 will test whether lowering the levels of ... -
Huntington’s Patients in US and Canada Being Enrolled in Phase 3 Study of RG6042
A Phase 3 clinical trial is enrolling adults with Huntington’s disease across the United ... -
FDA Clears First Clinical Study of AMT-130 Gene Therapy in Huntington’s disease
uniQure is launching a Phase 1/2 trial in the United States to evaluate the ... -
Brain Neurons Disconnect from Each Other in Process Called Neuritosis, Mouse Study of Huntington’s Reveals
The progressive death of brain nerve cells observed in Huntington’s disease is likely preceded by ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Blocking 2 Enzymes Seen to Reduce Nerve Cell Loss in Fruit Fly Model of Huntington’s
News
A collaboration between researchers at the University of Leicester, U.K., and the University of Maryland School of Medicine, Baltimore, may lead to a way of reversing some symptoms of neurogedenerative diseases, like Huntington’s, by blocking two specific enzymes of the kynurenine ... Read more